Lacklustre PPL threatens US move
Tuesday 27 April 1999
The company also threatened to move to the United States if it could not secure funding for a new plant.
PPL is struggling to raise pounds 45m to build a new facility in Scotland. It claims it has received offers from American states, including Virginia, but admits it could be difficult to persuade its scientists to make the move.
The plant would be used to develop AAT, a cystic fibrosis treatment. AAT, which aims to reduce the lung infections caused by cystic fibrosis, is derived from the milk of genetically modified sheep and is the group's most advanced product. It aims to begin phase three of clinical trials within the next year with the backing of a partner.
The City had expected the 35 per cent rise in pre-tax losses to pounds 14.25m, but analysts said they had been hoping for an announcement regarding the partner needed to fund the launch of AAT. Nick Woolf, senior analyst at BancBoston Robertson Stephens, said: "They're still missing the elusive partner we've been expecting for some time.
"They need the partner to fund phase three and to validate the drug. With pounds 25.8m cash they've got another 18 months' money, but we know they'll need more," said Mr Woolf.
Dr Ron James, PPL managing director, said that the February results of the phase two clinical trials of AAT were "very pleasing".
Dr James added that "initial reactions from two of our potential marketing partners are very positive". Nonetheless, analysts concede that the sector has suffered unduly from excessive hype which has fuelled unrealistic expectations.
"PPL is attractive," said Mr Woolf. "They are at a quarter of the price they were at when they went public, but they have clearly made progress since then with AAT."
Julie Simmons, biotech analyst at Beeson Gregory, said: "We're not quite as bullish as in the past, but we still consider that the shares are undervalued. On a fundamental basis they should be a buy."
- 1 I've been called an abusive and dangerous parent, when all I did was listen to my transgender child
- 2 Why this father didn’t hide his daughter’s heroin overdose in her obituary
- 3 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
- 4 Teaching profession headed for crisis as numbers continue to drop and working lives become 'unbearable'
- 5 The most powerful passports in the world
Nepal earthquake in pictures: Photos show devastation caused by 7.8 magnitude earthquake
Smartphones are making children borderline autistic, says psychiatrist
Nepal earthquake: The race is on to help thousands trapped under rubble around Kathmandu, while remote villages face a long wait for help
Royal baby: Live updates as superbug closes ward at St Mary's Hospital where Duchess of Cambridge is due to give birth
Teaching profession headed for crisis as numbers continue to drop and working lives become 'unbearable'
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband
The sickening truth about food banks that the Tories don't want you to know
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
General Election 2015: Britain would become a 'communist dictatorship' under Ed Miliband and Nicola Sturgeon, claims wife of Michael Gove
iJobs Money & Business
£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...
£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...
£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...